Loading...
Sakar Healthcare Limited — Flucloxacillin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #11 for Flucloxacillin · $447.2K export value · DGFT Verified
Sakar Healthcare Limited is the #11 Indian exporter of Flucloxacillin with $447.2K in export value and 32 verified shipments. Sakar Healthcare Limited holds a 1.2% market share in Flucloxacillin exports across 5 countries. The company exports 6 pharmaceutical products worth $16.0M across 4 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $270.3K | 15 | 60.3% |
| CAMEROON | $113.2K | 12 | 25.3% |
| THAILAND | $43.3K | 2 | 9.7% |
| MOZAMBIQUE | $15.6K | 3 | 3.5% |
| MALAWI | $5.6K | 1 | 1.3% |
Sakar Healthcare Limited exports Flucloxacillin to 5 countries. The largest destination is MYANMAR accounting for 60.3% of Sakar Healthcare Limited's Flucloxacillin shipments, followed by CAMEROON (25.3%) and THAILAND (9.7%). These destinations reflect Sakar Healthcare Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. ROYAL DISTRIBUTION CO. LTD. | MYANMAR | $95.0K | 4 |
| M/S. PHARMA-ROC S.A.R.L. REPARTITEU | CAMEROON | $56.2K | 9 |
| ROYAL DISTRIBUTION CO. LTD. | MYANMAR | $56.1K | 6 |
| ROYAL DISTRIBUTION CO LIMITED | MYANMAR | $50.0K | 1 |
| ROYAL DISTRIBUTION CO. LIMITED | MYANMAR | $50.0K | 1 |
| NSD TRADING CO LTD | THAILAND | $43.3K | 2 |
India exported $30.0M worth of Flucloxacillin through 1,146 shipments from 123 suppliers to 44 countries, serving 198 buyers globally. Sakar Healthcare Limited contributes $447.2K to this total, accounting for 1.2% of India's Flucloxacillin exports. Sakar Healthcare Limited ships Flucloxacillin to 5 countries through 12 buyers.
Sakar Healthcare Limited's average Flucloxacillin shipment value is $14.0K per consignment, based on 32 shipments totaling $447.2K. The largest destination is MYANMAR (60.3% of Sakar Healthcare Limited's Flucloxacillin exports).
Sakar Healthcare Limited ranks #11 among 123 Indian Flucloxacillin exporters with a 1.2% market share. The top 3 exporters are MEDREICH LIMITED ($16.9M), MICRO LABS LIMITED ($4.0M), AUROBINDO PHARMA LTD ($1.7M). Sakar Healthcare Limited processed 32 shipments to 5 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULE 2 | $64.0K | 2 |
| AMOXYCILLIN & FLUCLOXACILLIN CAPSULES SUPRAMOX DRY SYRUP AS PER DOCUMENT | $50.0K | 1 |
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULES(SUPRAMOX CAPSULE) | $50.0K | 1 |
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULES(SUPRAMOX CAPSULE)NOS | $42.0K | 3 |
| AMOXYCILLIN & FLUCLOXACILLIN FOR ORAL SU | $31.1K | 2 |
| SUPRAMOX CAPSULE AMOXICILLIN AND FLUCLOXACILLIN CAPSULES | $28.3K | 1 |
| FLUCLOX 500 - CAMEROON ( FLUCLOXACILLINCAPSULES BP 500 MG.) | $26.9K | 3 |
| FLUCLOXACILLIN CAPSULES BP 500 MG. ( FLUCLOX 500) BATCH NO.: C25202, MFG: 03-2025, EXP: 02-2027 | $22.8K | 1 |
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | AUROBINDO PHARMA LIMITED | $639.9K | 22 | 1 | $29.1K |
| 10 | MEDOPHARM PRIVATE LIMITED | $499.9K | 25 | 5 | $20.0K |
| 11 | SAKAR HEALTHCARE LIMITED ★ | $447.2K | 32 | 5 | $14.0K |
| 12 | MILAN LABORATORIES INDIA PRIVATE LIMITED | $350.0K | 7 | 2 |
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 140 | 12.2% |
| BANGALORE ICD (INWFD6) | 107 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 100 | 8.7% |
| JNPT | 76 | 6.6% |
| BANGALORE ACC (INBLR4) | 69 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 55 | 4.8% |
| SAHAR AIR | 50 | 4.4% |
| BANGALORE AIR | 36 | 3.1% |
Sakar Healthcare Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Sakar Healthcare's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have disrupted Red Sea shipping routes, leading to increased freight costs and potential delays. The Pharmaceuticals Export Promotion Council of India estimates that the domestic pharma industry could face losses between ₹2,500 crore and ₹5,000 crore due to these disruptions. (medicaldialogues.in) As a company with significant export activities, Sakar may need to explore alternative logistics strategies to mitigate these challenges.
In the United States, recent tariff policies have introduced uncertainties for Indian pharmaceutical exporters. While health products have been exempt from U.S. tariffs, there have been threats to impose significant increases to encourage domestic production. This situation necessitates vigilance from companies like Sakar to adapt to potential policy shifts. (lemonde.fr)
European Union regulatory changes, such as the Falsified Medicines Directive, impose stringent compliance requirements on pharmaceutical imports. Sakar's recent marketing authorizations in Europe suggest a proactive approach to meeting these standards, enhancing its competitiveness in the EU market. (prysm.fi)
Compliance with international regulatory standards is crucial for Indian pharmaceutical exporters. Sakar Healthcare's successful acquisition of marketing authorizations in Europe indicates adherence to Good Manufacturing Practices (GMP) and other regulatory requirements. Additionally, the company's development of in-house APIs and obtaining Written Confirmations reflect a commitment to quality and regulatory compliance. (prysm.fi)
Sakar Healthcare Limited exports 6 products worth $16.0M. Beyond Flucloxacillin, top products include Cefixime, Ceftriaxone, Heparin, Dexamethasone, Diazepam. View the complete Sakar Healthcare Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Flucloxacillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sakar Healthcare Limited's Flucloxacillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sakar Healthcare Limited
Full Company Profile →
6 products · $16.0M total trade · 4 categories
| PHARMA-ROC S.A.R.L. REPARTITEUR | CAMEROON | $37.0K | 2 |
| PHARMA ROC S A R L REPARTITEU | CAMEROON | $20.0K | 1 |
| ROYAL DISTRIBUTION CO LTD | MYANMAR | $19.1K | 3 |
| PHARMACHEMIE LTD | MOZAMBIQUE | $6.4K | 1 |
Sakar Healthcare Limited supplies Flucloxacillin to 12 buyers globally. The largest buyer is M/S. ROYAL DISTRIBUTION CO. LTD. (MYANMAR), followed by M/S. PHARMA-ROC S.A.R.L. REPARTITEU (CAMEROON) and ROYAL DISTRIBUTION CO. LTD. (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| FLUCLOXACILLIN CAPSULES BP 500 MG.(FLUCLOX 500) BATCH NO.: C23209 MFG: 06-2023 EXP: 05-2025 (ASPERINV) | $20.0K | 1 |
| FLUCLOX 500 (FLUCLOXACILLIN CAPSULES BP500 MG) BATCH: C24203, MFG: 01-2024, EXP: 12-2025NOS | $18.0K | 3 |
Sakar Healthcare Limited exports 21 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMOXICILLIN AND FLUCLOXACILLIN CAPSULE 2 with 2 shipments worth $64.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
| $50.0K |
| 13 | SCOTT EDIL PHARMACIA LIMITED | $320.4K | 22 | 9 | $14.6K |
Sakar Healthcare Limited ranks #11 among 123 Indian Flucloxacillin exporters. Average shipment value of $14.0K compared to the market average of $243.5K. The closest competitors by value are AUROBINDO PHARMA LIMITED and MEDOPHARM PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 198+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Sakar Healthcare Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Flucloxacillin. For current shipment-level data, contact TransData Nexus.